• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过3D打印实现组织血管化:技术会为我们带来血流吗?

Tissue vascularization through 3D printing: Will technology bring us flow?

作者信息

Paulsen S J, Miller J S

机构信息

Department of Bioengineering, Rice University, Houston, Texas.

出版信息

Dev Dyn. 2015 May;244(5):629-40. doi: 10.1002/dvdy.24254. Epub 2015 Apr 21.

DOI:10.1002/dvdy.24254
PMID:25613150
Abstract

BACKGROUND

Though in vivo models provide the most physiologically relevant environment for studying tissue function, in vitro studies provide researchers with explicit control over experimental conditions and the potential to develop high throughput testing methods. In recent years, advancements in developmental biology research and imaging techniques have significantly improved our understanding of the processes involved in vascular development. However, the task of recreating the complex, multi-scale vasculature seen in in vivo systems remains elusive.

RESULTS

3D bioprinting offers a potential method to generate controlled vascular networks with hierarchical structure approaching that of in vivo networks. Bioprinting is an interdisciplinary field that relies on advances in 3D printing technology along with advances in imaging and computational modeling, which allow researchers to monitor cellular function and to better understand cellular environment within the printed tissue.

CONCLUSIONS

As bioprinting technologies improve with regards to resolution, printing speed, available materials, and automation, 3D printing could be used to generate highly controlled vascularized tissues in a high throughput manner for use in regenerative medicine and the development of in vitro tissue models for research in developmental biology and vascular diseases.

摘要

背景

尽管体内模型为研究组织功能提供了最接近生理状态的环境,但体外研究使研究人员能够明确控制实验条件,并有可能开发高通量测试方法。近年来,发育生物学研究和成像技术的进步显著增进了我们对血管发育相关过程的理解。然而,在体外重现体内系统中所见的复杂多尺度脉管系统仍然是一项艰巨的任务。

结果

3D生物打印提供了一种潜在方法,可生成具有接近体内网络层次结构的可控血管网络。生物打印是一个跨学科领域,它依赖于3D打印技术的进步以及成像和计算建模的进展,这使研究人员能够监测细胞功能,并更好地了解打印组织内的细胞环境。

结论

随着生物打印技术在分辨率、打印速度、可用材料和自动化方面的改进,3D打印可用于以高通量方式生成高度可控的血管化组织,用于再生医学以及开发用于发育生物学和血管疾病研究的体外组织模型。

相似文献

1
Tissue vascularization through 3D printing: Will technology bring us flow?通过3D打印实现组织血管化:技术会为我们带来血流吗?
Dev Dyn. 2015 May;244(5):629-40. doi: 10.1002/dvdy.24254. Epub 2015 Apr 21.
2
3D Bioprinting for Vascularized Tissue Fabrication.用于血管化组织构建的3D生物打印
Ann Biomed Eng. 2017 Jan;45(1):132-147. doi: 10.1007/s10439-016-1653-z. Epub 2016 May 26.
3
[Biofabrication: new approaches for tissue regeneration].[生物制造:组织再生的新方法]
Handchir Mikrochir Plast Chir. 2018 Apr;50(2):93-100. doi: 10.1055/s-0043-124674. Epub 2018 Jan 29.
4
Tissue Engineering Applications of Three-Dimensional Bioprinting.三维生物打印的组织工程应用
Cell Biochem Biophys. 2015 Jul;72(3):777-82. doi: 10.1007/s12013-015-0531-x.
5
3D bioprinting and the current applications in tissue engineering.3D生物打印及其在组织工程中的当前应用。
Biotechnol J. 2017 Aug;12(8). doi: 10.1002/biot.201600734. Epub 2017 Jul 4.
6
3D bioprinting for drug discovery and development in pharmaceutics.用于制药领域药物发现与开发的3D生物打印技术。
Acta Biomater. 2017 Jul 15;57:26-46. doi: 10.1016/j.actbio.2017.05.025. Epub 2017 May 10.
7
3D-printed biological organs: medical potential and patenting opportunity.3D打印生物器官:医学潜力与专利机遇
Expert Opin Ther Pat. 2015 May;25(5):507-11. doi: 10.1517/13543776.2015.1019466. Epub 2015 Feb 24.
8
Three-dimensional bioprinting in tissue engineering and regenerative medicine.组织工程与再生医学中的三维生物打印
Biotechnol Lett. 2016 Feb;38(2):203-11. doi: 10.1007/s10529-015-1975-1. Epub 2015 Oct 14.
9
Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues.时空引导宿主和工程组织血管生成的综合方法。
Acta Biomater. 2018 Mar 15;69:42-62. doi: 10.1016/j.actbio.2018.01.017. Epub 2018 Jan 31.
10
A Review of 3D Printing Techniques and the Future in Biofabrication of Bioprinted Tissue.3D打印技术综述及生物打印组织生物制造的未来
Cell Biochem Biophys. 2016 Jun;74(2):93-8. doi: 10.1007/s12013-016-0730-0. Epub 2016 May 18.

引用本文的文献

1
3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine.用于神经修复的3D打印:弥合再生医学的差距。
Adv Mater. 2025 Sep;37(36):e07590. doi: 10.1002/adma.202507590. Epub 2025 Jul 30.
2
Enhancing Viability in Static and Perfused 3D Tissue Constructs Using Sacrificial Gelatin Microparticles.使用牺牲性明胶微粒提高静态和灌注3D组织构建物的活力
ACS Biomater Sci Eng. 2025 May 12;11(5):2888-2897. doi: 10.1021/acsbiomaterials.4c02169. Epub 2025 Apr 7.
3
From Soft Lithography to 3D Printing: Current Status and Future of Microfluidic Device Fabrication.
从软光刻到3D打印:微流控设备制造的现状与未来
Polymers (Basel). 2025 Feb 9;17(4):455. doi: 10.3390/polym17040455.
4
3D-Printed Polymeric Biomaterials for Health Applications.用于健康应用的3D打印聚合物生物材料。
Adv Healthc Mater. 2025 Jan;14(1):e2402571. doi: 10.1002/adhm.202402571. Epub 2024 Nov 5.
5
Three-Dimensional Bioprinting in Soft Tissue Engineering for Plastic and Reconstructive Surgery.用于整形和重建手术的软组织工程中的三维生物打印
Bioengineering (Basel). 2023 Oct 21;10(10):1232. doi: 10.3390/bioengineering10101232.
6
Technology platform for facile handling of 3D hydrogel cell culture scaffolds.用于方便处理 3D 水凝胶细胞培养支架的技术平台。
Sci Rep. 2023 Aug 7;13(1):12829. doi: 10.1038/s41598-023-39081-x.
7
3D Bioprinting for Vascularization.用于血管化的3D生物打印
Bioengineering (Basel). 2023 May 18;10(5):606. doi: 10.3390/bioengineering10050606.
8
Generation of a Perfusable 3D Lung Cancer Model by Digital Light Processing.基于数字光处理技术的可灌注 3D 肺癌模型的构建。
Int J Mol Sci. 2023 Mar 23;24(7):6071. doi: 10.3390/ijms24076071.
9
Advances of 3D Printing in Vascularized Organ Construction.3D打印在血管化器官构建中的进展
Int J Bioprint. 2022 Jul 7;8(3):588. doi: 10.18063/ijb.v8i3.588. eCollection 2022.
10
Lymphatic Tissue and Organ Engineering for In Vitro Modeling and In Vivo Regeneration.用于体外建模和体内再生的淋巴组织与器官工程
Cold Spring Harb Perspect Med. 2022 Mar 14;12(9). doi: 10.1101/cshperspect.a041169.